RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Liraglutide is a Safe and Beneficial Adjunct to Insulin in Glycemic Control in Type 1 Diabetes
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 17
SP 9
OP 10
DO 10.1177/155989771317005
UL http://mdc.sagepub.com/content/13/17/9.2.abstract
AB This article reports on the short-term findings of a randomized, double-blind, placebo-controlled crossover trial that demonstrated the prowess of the glucagon-like peptide-1 analogue liraglutide, used as an adjunct to insulin, in promoting glycemic control in type 1 diabetes [Heller SR et al. EASD 2013 (abstr 3); NCT01536665].